Shire partners with MicroHealth to develop hemophilia tool
Shire plc (LSE:SHP; NASDAQ:SHPG) said it is collaborating with digital health company MicroHealth LLC (Vienna, Va.) to customize MicroHealth's existing monitoring tool for use among hemophilia A and B patients who have developed neutralizing antibodies against clotting factor replacement drugs.
In 2011, MicroHealth launched the digital monitoring tool to help hemophilia patients manage their treatment and care. Shire spokesperson Molly Poarch said the company will provide funding, educational resources, and support services to enhance the app with new features and resources to specifically support patients with inhibitors. Poarch declined to provide financial details, but told BioCentury the app is available for all hemophilia patients regardless of their individual treatment regimens...